Stories Tagged as
Prescription drugs
Costco and Instacart expand deliveries to include prescription drugs
Apr 20, 2020
It's an effort to compete with drugstore chains and pharmacy startups.
House to vote on Speaker Pelosi's prescription drug bill this week
by
Andy Uhler
Dec 9, 2019
The plan would empower the Department of Health and Human Services to negotiate lower prices.
Why do foreign countries pay less than the U.S. for prescription drugs?
by
Amy Scott
Jul 9, 2019
The answer comes down to one key tactic: negotiation.
Drug summit looks at ways to prevent overdose deaths
Apr 23, 2019
President Trump expected to address the summit Wednesday.
Would requiring prices in pharmaceutical ads make drugs cheaper?
by
Andy Uhler
Apr 9, 2019
The idea is that transparency would lead to more competition and lower costs. One drug company is already on board.
Drug shortages continue to affect common meds
Mar 6, 2019
Contaminated supply chains, natural disasters, and the bottom line are just some of the reasons why basic drugs are in constant shortage.
The cost of preventing the spread of HIV? Upwards of $1,600 a month
by
Feb 5, 2019
President Trump is expected to call for an end to HIV transmission by 2030. The drug known as PrEP may be key.
You’ve got questions. We help you answer them.
Support nonprofit, independent journalism that makes you smarter.
Kickbacks or a helpful service? Here's why pharma is under fire
Sep 21, 2018
Drug companies can get creative with doctor incentives, and that can be problematic.
There's a new generic drugmaker in town, and it doesn't need to turn a profit
Sep 6, 2018
Across the country, hospitals and clinics are dealing with a really difficult problem: Sometimes they can’t get their hands on certain life-saving generic drugs. So one group of large hospital systems, including the Mayo Clinic and Intermountain Healthcare, has come up with a workaround. It’s created a nonprofit company called Civica RX that will make […]
Generic Viagra floods the market. Here’s how Pfizer is reacting
Jul 13, 2018
Pfizer hopes to run with its “little blue pill” as long as it can. That includes the time-honored strategy of launching its own generic.